Dysphagia is closely related to frailty in mild-to-moderate Alzheimer’s disease

被引：0
|
作者：
Merve Güner
Arzu Okyar Baş
Serdar Ceylan
Zeynep Kahyaoğlu
Süheyla Çöteli
Pelin Ünsal
Çağatay Çavuşoğlu
Cemile Özsürekci
Burcu Balam Doğu
Mustafa Cankurtaran
Meltem Gülhan Halil
机构：
[1] Hacettepe University,Faculty of Medicine, Department of Internal Medicine, Division of Geriatrics
来源：
BMC Geriatrics | / 23卷
关键词：
Dysphagia; Frailty; Dementia; Quality of life;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease
    M E Risner
    A M Saunders
    J F B Altman
    G C Ormandy
    S Craft
    I M Foley
    M E Zvartau-Hind
    D A Hosford
    A D Roses
    [J]. The Pharmacogenomics Journal, 2006, 6 : 246 - 254
  • [22] Estimating attrition in mild-to-moderate Alzheimer's disease and mild cognitive impairment clinical trials
    Ritchie, Marina
    Gillen, Daniel L.
    Grill, Joshua D.
    [J]. ALZHEIMERS RESEARCH & THERAPY, 2023, 15 (01)
  • [23] Correlating functional and cognitive decline in patients with mild-to-moderate Alzheimer's disease
    Feldman, H
    Kavanagh, S
    Van Baelen, B
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 257 - 258
  • [24] Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease
    Risner, M. E.
    Saunders, A. M.
    Altman, J. F. B.
    Ormandy, G. C.
    Craft, S.
    Foley, I. M.
    Zvartau-Hind, M. E.
    Hosford, D. A.
    Roses, A. D.
    [J]. PHARMACOGENOMICS JOURNAL, 2006, 6 (04): : 246 - 254
  • [25] Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
    Salloway, Stephen
    Sperling, Reisa
    Fox, Nick C.
    Blennow, Kaj
    Klunk, William
    Raskind, Murray
    Sabbagh, Marwan
    Honig, Lawrence S.
    Porsteinsson, Anton P.
    Ferris, Steven
    Reichert, Marcel
    Ketter, Nzeera
    Nejadnik, Bijan
    Guenzler, Volkmar
    Miloslavsky, Maja
    Wang, Daniel
    Lu, Yuan
    Lull, Julia
    Tudor, Iulia Cristina
    Liu, Enchi
    Grundman, Michael
    Yuen, Eric
    Black, Ronald
    Brashear, H. Robert
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (04): : 322 - 333
  • [26] Effects of Oral Rivastigmine on Cognitive Domains in Mild-to-Moderate Alzheimer's Disease
    Farlow, Martin R.
    Cummings, Jeffrey L.
    Olin, Jason T.
    Meng, Xiangyi
    [J]. AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2010, 25 (04): : 347 - 352
  • [27] Y Enrichment factors for clinical trials in mild-to-moderate Alzheimer's disease
    Ballard, Clive
    Atri, Alireza
    Boneva, Neli
    Cummings, Jeffrey L.
    Froelich, Lutz
    Luis Molinuevo, Jose
    Tariot, Pierre N.
    Raket, Lars Lau
    [J]. ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2019, 5 (01) : 164 - 174
  • [28] Obstructive sleep apnoea and cognitive decline in mild-to-moderate Alzheimer's disease
    Jorge, Carmen
    Targa, Adriano
    Benitez, Ivan David
    Dakterzada, Faride
    Torres, Gerard
    Minguez, Olga
    Carnes, Anna
    Pujol, Montse
    Gibert, Aurora
    Lopez, Ricard
    Gaeta, Anna Michela
    Dalmases, Mireia
    Farre, Ramon
    Sanchez-de-la-Torre, Manuel
    Barbe, Ferran
    Pinol-Ripoll, Gerard
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56 (05)
  • [29] Safety and efficacy of donepezil in African Americans with mild-to-moderate Alzheimer's disease
    Griffith, Patrick
    Lichtenberg, Peter
    Goldman, Robert
    Payne-Parrish, Jennifer
    [J]. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2006, 98 (10) : 1590 - 1597
  • [30] Phase II Crossover Trial of Varenicline in Mild-to-Moderate Alzheimer's Disease
    Kim, Seong Yoon
    Choi, Seong Hye
    Rollema, Hans
    Schwam, Elias M.
    McRae, Tom
    Dubrava, Sarah
    Jacobsen, Janice
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2014, 37 (3-4) : 232 - 245
12345